Figure 2 | Scientific Reports

Figure 2

From: Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysis

Figure 2

Forest plot showing the risk difference for studies in ICU setting in mortality between patients treated with IL-6 (receptor) antagonists and patients not treated with IL-6 (receptor) antagonists. I2 was 0%. The Metafor R package was used to generate this figure13,23. IL6Ra = IL-6 (receptor) antagonist, TCZ = tocilizumab, SAR = sarilumab, * = RCT.

Back to article page